UNSPSC 51111831: Acolbifene
Commodity
Code facts
- Part of
-
-
51000000
-
51110000
- 51111800
-
51110000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51111831
| NIGP code |
|---|
| 26968 Hormones and Synthetic Substitutes |
Definition
This classification denotes a selective estrogen receptor modulator with the molecular formula C29H31NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 815LJ9X0D1, chemically known as 2h-1-benzopyran-7-ol, 3-(4-hydroxyphenyl)-4-methyl-2-(4-(2-(1-piperidinyl)ethoxy)phenyl)-, (2s) but generally known as acolbifene, which bears US NIH Compound Identifier 155435. Acolbifene most often comes in base and hydrochloride forms. Acolbifene also comes in hydrochloride form.
Read the full definition
The term ACOLBIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3, 2002, List 48). Most nations schedule acolbifene under HS 29349990 and SITC 51579. As of Q4 2014, ACOLBIFENE remains the US FDA Preferred Term for this commodity. Acolbifene bears US NLM identifiers UMLS ID C1122255 and NCI Concept Code C64183. SMILES: CC1=C([C@@H](OC2=C1C=CC(=C2)O)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O.
About UNSPSC 51111831
UNSPSC 51111831 Acolbifene is a Commodity code under which state and local government procurement offices and cooperative purchasing alliances source generic pharmaceuticals and over-the-counter products for distribution across participating facilities. The code captures pharmaceutical manufacturers and suppliers responding to multi-state cooperative purchasing solicitations that require cGMP certification, FDA compliance, Drug Supply Chain Security Act adherence, and direct or wholesaler-mediated distribution agreements tied to specific National Drug Codes, pricing structures, and administrative fee arrangements.
The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal on January 20, 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products effective July 1, 2026, with proposals due March 26, 2026. Vendors must maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, or Morris & Dickson Co., LLC), hold $5 million in commercial general liability insurance and $2 million each in network security and professional liability coverage, and offer pricing flexibility through flat price, net price (NF30, NF60, NF90), or WAC-minus formats. The evaluation weights price competitiveness at 75 percent, with the remaining 25 percent distributed across fixed pricing, administrative compliance, EDI capability, and acceptance of a 3 percent administrative fee. The contract runs two years for new responders with optional extensions, and performance violations carry penalties ranging from $200 to $1,500 per incident.
Quick answers
What is UNSPSC 51111831?
UNSPSC 51111831 is Acolbifene, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51111831?
UNSPSC 51111831 maps to 1 NIGP code, 26968 Hormones and Synthetic Substitutes.
On GovTribe
See everything under UNSPSC 51111831
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code